The potential of novel biomarkers to improve risk prediction of type 2 diabetes

Diabetologia

Volumn 57, Issue 1, 2014, Pages 16-29

  Herder, Christian ^a   Kowall, Bernd ^a   Tabak, Adam G ^b,c   Rathmann, Wolfgang ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Biomarkers; Calibration; Discrimination; Genetic variants; Metabolomics; Prediction models; Reclassification; Repeated measures; Review; Risk Scores; Type 2 diabetes

Indexed keywords

BIOLOGICAL MARKER; LIPID; PEPTIDES AND PROTEINS; RNA;

CALIBRATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; EXTERNAL VALIDITY; GENETIC VARIABILITY; HUMAN; INTERNAL VALIDITY; METABOLITE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REVIEW; RISK; RISK ASSESSMENT; RNA TRANSCRIPTION; TRANSCRIPTOMICS;

BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; RISK FACTORS; ROC CURVE;

EID: 84890907150     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-013-3061-3     Document Type: Review

References (100)

1. Buijsse B, Simmons RK, Griffin SJ, Schulze MB (2011) Risk assessment tools for identifying individuals at risk of developing type 2 diabetes. Epidemiol Rev 33:46-62
2. Noble D, Mathur R, Dent T, Meads C, Greenhalgh T (2011) Risk models and scores for type 2 diabetes: systematic review. BMJ 343:d7163
3. Abbasi A, Peelen LM, Corpeleijn E et al (2012) Prediction models for risk of developing type 2 diabetes: systematic literature search and independent external validation study. BMJ 345:e5900
4. Moons KGM, Kengne AP, Woodward M et al (2012) Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker. Heart 98:683-690
5. Moons KGM, Kengne AP, de Grobbee et al (2012) Risk prediction models: II. External validation, model updating, and impact assessment. Heart 98:691-698
6. Collins GS, Mallett S, Omar O, Yu LM (2011) Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting. BMC Med 9:103
7. Cook NR (2007) Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 115:928-935
8. Kowall B, Rathmann W, Strassburger K (2013) Use of areas under the receiver operating curve (AROCs) and some caveats. Int J Public Health 58:485-488
9. DeLong ER, DeLong DM, Clarke Pearson DL (1988) Comparing the areas under two or more correlated receiver-operating characteristic curves; a nonparametric approach. Biometrics 44:837-845
10. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS (2008) Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27:157-172
11. Greenland S (2008) The need for reorientation toward cost-effective prediction: comments on 'Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond' by M. J. Pencina et al, Statistics in Medicine (DOI: 10.1002/sim.2929). Stat Med 27:199-206
12. Mühlenbruch K, Heraclides A, Steyerberg EW, Joost HG, Boeing H, Schulze MB (2013) Assessing improvement in disease prediction using net reclassification improvement: impact of risk cut-offs and number of risk categories. Eur J Epidemiol 28:25-33
13. Leening MJG, Cook NR (2013) Net reclassification improvement: a link between statistics and clinical practice. Eur J Epidemiol 28:21-23
14. Pencina MJ, D'Agostino RB, Pencina KM, Janssens AC, Greenland P (2012) Interpreting incremental value of markers added to risk prediction models. Am J Epidemiol 76:473-481
15. Pencina MJ, D'Agostino RB, Steyerberg EW (2011) Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 30:11-21
16. Janssen KJM, Moons KGM, Kalkman CJ, Grobbe DE, Vergouwe Y (2008) Updating methods improved the performance of a clinical prediction model in new patients. J Clin Epidemiol 61:76-86
17. Rahman M, Simmons RK, Harding AH, Wareham NJ, Griffin SJ (2008) A simple risk score identifies individuals at high risk of developing type 2 diabetes: a prospective cohort study. Fam Pract 25:191-196
18. Rathmann W, Kowall B, Heier M et al (2010) Prediction models for incident type 2 diabetes mellitus in the older population: KORA S4/F4 cohort study. Diabet Med 27:1116-1123
19. Lindström J, Tuomilehto J (2003) The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 26:725-731
20. Hippisley-Cox J, Coupland C, Robson J, Sheikh A, Brindle P (2009) Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore. BMJ 338:b880
21. Chen L, Magliano DJ, Balkau B et al (2010) AUSDRISK: an Australian Type 2 Diabetes Risk Assessment Tool based on demographic, lifestyle and simple anthropometric measures. Med J Aust 192:197-202
22. Kahn HS, Cheng YJ, Thompson TJ, Imperatore G, Gregg EW (2009) Two risk-scoring systems for predicting incident diabetes mellitus in U.S. adults age 45 to 64 years. Ann Intern Med 150:741-751
23. Stern MP, Williams K, Haffner SM (2002) Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Ann Intern Med 136:575-581
24. Schmidt MI, Duncan BB, Bang H et al (2005) Identifying individuals at high risk for diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care 28:2013-2018
25. Wilson PW, Meigs JB, Sullivan L, Fox CS, Nathan DM, D'Agostino RB Sr (2007) Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med 167:1068-1074
26. Talmud PJ, Hingorani AD, Cooper JA et al (2010) Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study. BMJ 340:b4838
27. Abbasi A, Corpeleijn E, Peelen LM et al (2012) External validation of the KORA S4âF4 prediction models for the risk of developing type 2 diabetes in older adults: the PREVEND Study. Eur J Epidemiol 27:47-52
28. Alssema M, Vistisen D, Heymans MW et al (2011) The Evaluation of Screening and Early Detection Strategies for Type 2 Diabetes and Impaired Glucose Tolerance (DETECT-2) update of the Finnish diabetes risk score for prediction of incident type 2 diabetes. Diabetologia 54:1004-1012
29. Collins GS, Altman DG (2011) External validation of QDSCORE® for predicting the 10-year risk of developing type 2 diabetes. Diabet Med 28:599-607
30. Mann DM, Bertoni AG, Shimbo D et al (2010) Comparative validity of 3 diabetes mellitus risk prediction scoring models in a multiethnic US cohort: the Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol 171:980-988
31. 1c 6.0-6.4% and other prediabetes definitions to type 2 diabetes: a meta-analysis. Diabetologia 56:1489-1493
32. Rathmann W, Strassburger K, Heier M et al (2009) Incidence of type 2 diabetes in the elderly German population and the effect of clinical and lifestyle risk factors: KORA S4/F4 cohort study. Diabet Med 26:1212-1219
33. Faerch K, Borch-Johnsen K, Holst JJ, Vaag A (2009) Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes? Diabetologia 52:1714-1723
34. Tirosh A, Shai I, Tekes-Manova D et al (2005) Normal fasting plasma glucose levels and type 2 diabetes in young men. N Engl J Med 353:1454-1462
35. Kolberg JA, Jorgensen T, Gerwien RW et al (2009) Development of a type 2 diabetes risk model from a panel of serum biomarkers from the Inter99 cohort. Diabetes Care 32:1207-1212
36. Kowall B, Rathmann W, Giani G et al (2013) Random glucose is useful for individual prediction of type 2 diabetes: results of the Study of Health in Pomerania (SHIP). Prim Care Diabetes 7:25-31
37. Schöttker B, Raum E, Rothenbacher D, Müller H, Brenner H (2011) Prognostic value of haemoglobin A1c and fasting plasma glucose for incident diabetes and implications for screening. Eur J Epidemiol 26:779-787
38. Heianza Y, Arase Y, Hsieh SD et al (2012) Development of a new scoring system for predicting the 5 year incidence of type 2 diabetes in Japan: the Toranomon Hospital Health Management Center Study 6 (TOPICS 6). Diabetologia 55:3213-3223
39. Herder C, Karakas M, Koenig W (2011) Biomarkers for the prediction of type 2 diabetes and cardiovascular disease. Clin Pharmacol Ther 90:52-66
40. Nolan CJ, Damm P, Prentki M (2011) Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet 378:169-181
41. Kooner JS, Saleheen D, Sim X et al (2011) Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci. Nat Genet 43:984-989
42. Cho YS, Chen CH, Hu C et al (2011) Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians. Nat Genet 44:67-72
43. Morris AP, Voight BF, Teslowich TM et al (2012) Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet 44:981-990
44. Pal PA, McCarthy MI (2013) The genetics of type 2 diabetes and its clinical relevance. Clin Genet 83:297-306
45. Dupuis J, Langenberg C, Prokopenko I et al (2010) New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 42:105-116
46. Scott RA, Lagou V, Welch RP et al (2012) Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet 44:991-1005
47. Voight BF, Scott LJ, Steinthorsdottir V et al (2010) Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 42:579-589
48. Manning AK, Hivert MF, Scott RA et al (2012) A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet 44:659-669
49. McCarthy MI (2010) Genomics, type 2 diabetes, and obesity. N Engl J Med 363:2339-2350
50. InterAct Consortium (2013) The link between family history and risk of type 2 diabetes is not explained by anthropometric, lifestyle or genetic risk factors: the EPIC-InterAct study. Diabetologia 56:60-69
51. Herder C, Roden M (2011) Genetics of type 2 diabetes. Pathophysiologic and clinical relevance. Eur J Clin Invest 41:679-692
52. Willems SM, Mihaescu R, Sijbrands EJG, van Duijn CM, Janssens AC (2011) A methodological perspective on genetic risk prediction studies in type 2 diabetes: recommendations for future research. Curr Diab Rep 11:511-518
53. de Miguel-Yanes JM, Shrader P, Pencina MJ et al (2011) Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms. Diabetes 34:121-125
54. Lyssenko V, Jonsson A, Almgren P et al (2008) Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med 359:2220-2232
55. Vassy JL, DasMahapatra P, Meigs JB et al (2012) Genotype prediction of adult type 2 diabetes from adolescence in a multiracial population. Pediatrics 130:e1235-e1242
56. Vassy JL, Meigs JB (2012) Is genetic testing useful to predict type 2 diabetes? Best Pract Res Clin Endocrinol Metab 26:189-201
57. Cooke JN, Ng MCY, Palmer ND et al (2012) Genetic risk assessment of type 2 diabetes-associated polymorphisms in African Americans. Diabetes Care 35:287-292
58. Vassy JL, Durant NH, Kabagambe EK et al (2012) A genotype risk score predicts type 2 diabetes from young adulthood: the CARDIA study. Diabetologia 55:2604-2612
59. Hu C, Zhang R, Wang C et al (2009) PPARG, KCNJ11, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGFBP2 and SLC30A8 are associated with type 2 diabetes in a Chinese population. PLoS One 4:e7643
60. Miyake K, Yang W, Hara K et al (2009) Construction of a prediction model for type 2 diabetes mellitus in the Japanese population based on 11 genes with strong evidence of association. J Hum Genet 54:236-241
61. Qi Q, Li H, Wu Y et al (2010) Combined effects of 17 common genetic variants on type 2 diabetes risk in a Han Chinese population. Diabetologia 53:2163-2166
62. Chen R, Corona E, Sikora M et al (2012) Type 2 diabetes risk alleles demonstrate extreme directional differentiation among human populations, compared to other diseases. PLoS Genet 8:e10002621
63. Bonnefond A, Clément N, Fawcett K et al (2012) Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes. Nat Genet 44:297-301
64. Albrechtsen A, Grarup N, Li Y et al (2013) Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes. Diabetologia 56:298-310
65. The 1000 Genomes Project Consortium (2012) An integrated map of genetic variation from 1,092 human genomes. Nature 491:56-65
66. Day-Williams AG, Zeggini E (2011) The effect of next-generation sequencing technology on complex trait research. Eur J Clin Invest 41:561-567
67. Herder C, Roden M, Carstensen M, Illig T (2012) Transcriptomics und typ-2-diabetes. Diabetologe 8:35-41 [article in German]
68. Schurmann C, Heim K, Schillert A et al (2012) Analyzing Illumina gene expression microarray data from different tissues: methodological aspects of data analysis in the MetaXpress Consortium. PLoS One 7:e50938
69. Fernandez-Valverde SL, Taft RJ, Mattick JS (2011) MicroRNAs in beta-cell biology, insulin resistance, diabetes and ist complications. Diabetes 60:1825-1831
70. Williams MD, Mitchell GM (2012) MicroRNAs in insulin resistance and obesity. Exp Diab Res 2012:484696
71. Zampetaki A, Kiechl S, Drozdov I et al (2010) Plasma microRNA profiling reveals loss of endothelial MiR-126 and other microRNAs in type 2 diabetes. Circ Res 107:810-817
72. Drong AW, Lindgren CM, McCarthy MI (2012) The genetic and epigenetic basis of type 2 diabetes and obesity. Clin Pharmacol Ther 92:707-715
73. Anderson NL, Anderson NG (2002) The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 1:845-867
74. Sundsten T, Ortsäter H (2009) Proteomics in diabetes research. Mol Cell Endocrinol 297:93-103
75. Herder C, Baumert J, Zierer A et al (2011) Immunological and cardiometabolic risk factors in the prediction of type 2 diabetes and coronary events: MONICA/KORA Augsburg case-cohort study. PLoS One 6:e19852
76. Ley SH, Harris SB, Connelly PW et al (2008) Adipokines and incident type 2 diabetes in an Aboriginal Canadian Population. The Sandy Lake Health and Diabetes Project. Diabetes Care 31:1410-1415
77. Schulze MB, Weikert C, Pischon T et al (2009) Use of multiple metabolic and genetic markers to improve the prediction of type 2 diabetes: the EPIC-Potsdam Study. Diabetes Care 32:2116-2119
78. Salomaa V, Havulinna A, Saarela O et al (2010) Thirty-one novel biomarkers as predictors for clinically incident diabetes. PLoS One 5:e10100
79. Chao C, Song Y, Cook N et al (2010) The lack of utility of circulating biomarkers of inflammation and endothelial dysfunction for type 2 diabetes risk prediction among postmenopausal women. The Women's Health Initiative Observational Study. Arch Intern Med 170:1557-1565
80. Lyssenko V, Jorgensen T, Gerwien RW et al (2012) Validation of a multi-marker model for the prediction of incident type 2 diabetes mellitus: combined results of the Inter99 and Botnia studies. Diab Vasc Dis Res 9:59-67
81. Jensen TM, Witte DR, Pieragostino D et al (2013) Association between protein signals and type 2 diabetes incidence. Acta Diabetol. doi: 10.1007/s00592-012-0376-3
82. Bain JR, Stevens RD, Wenner BR, Ilkayeva O, Muoio DM, Newgard CB (2009) Metabolomics applied to diabetes research: moving from information to knowledge. Diabetes 58:2429-2443
83. Suhre K, Meisinger C, Döring A et al (2011) Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PLoS One 5:e13953
84. Wang TJ, Larson MG, Vasan RS et al (2011) Metabolite profiles and the risk of developing diabetes. Nat Med 17:448-453
85. Rhee EP, Chang S, Larson MG et al (2011) Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J Clin Invest 121:1402-1411
86. Stančáková A, Civelek M, Saleem NK et al (2012) Hyperglycemia and a common variant of GCKR are associated with the levels of eight amino acids in 9,369 Finnish men. Diabetes 61:1895-1902
87. Würtz P, Tiainen M, Mäkinen VP et al (2012) Circulating metabolite predictors of glycemia in middle-aged men and women. Diabetes Care 35:1749-1756
88. Wang-Sattler R, Yu Z, Herder C et al (2012) Novel biomarkers for pre-diabetes identified by metabolomics. Mol Syst Biol 8:615
89. Floegel A, Stefan N, Yu Z et al (2013) Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes 62:639-648
90. Würtz P, Soininen P, Kangas AJ et al (2013) Branched-chain and aromatic amino acids are predictors of insulin resistance in young adults. Diabetes Care 36:648-655
91. Ferrannini E, Natali A, Camastra S et al (2013) Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance. Diabetes 62:1730-1737
92. Carstensen M, Herder C, Kivimäki M et al (2010) Accelerated increase in serum interleukin-1 receptor antagonist starts 6 years before diagnosis of type 2 diabetes: Whitehall II prospective cohort study. Diabetes 59:1222-1227
93. 1c and fasting plasma glucose levels during the development of type 2 diabetes: the Toranomon Hospital Health Management Center Study 7 (TOPICS 7). Diabetes Care 35:1050-1052
94. Tabák AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimäki M, Witte DR (2009) Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 373:2215-2221
95. Tabák AG, Carstensen M, Witte DR et al (2012) Adiponectin trajectories before type 2 diabetes diagnosis: Whitehall II study. Diabetes Care 35:2540-2547
96. Sattar N, McConnachie A, Ford I et al (2007) Serial measurements and conversion to type 2 diabetes in the West of Scotland Coronary Prevention Study: specific elevations in alanine aminotransferase and triglycerides suggest hepatic fat accumulation as a potential contributing factor. Diabetes 56:984-991
97. Wald NJ, Morris JK (2011) Assessing risk factors as potential screening tests: a simple assessment tool. Arch Intern Med 171:286-291
98. Sattar N, Wannamethee SG, Forouhi NG (2008) Novel biochemical risk factors for type 2 diabetes: pathogenic insights or prediction possibilities? Diabetologia 51:926-940
99. Kowall B, Rathmann W, Bongaerts B et al (2013) Are diabetes risk scores useful for the prediction of cardiovascular diseases? Assessment of seven diabetes risk scores in the KORA S4/F4 cohort study. J Diabetes Complicat 27:340-345
100. Hlatky MA, Greenland P, Arnett DK et al (2009) Criteria for evaluation of novel markers of cardiovascular risk. A scientific statement from the American Heart Association. Circulation 119:2408-2416